Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.
Andrea KuemmerleCaecilia SchmidSonja BernhardVictor KandeWilfried MutomboMedard IlungaIsmael LumpunguSylvain MutandaPathou NganzoboDigas Ngolo TeteMays KisalaChristian BurriSeverine BlessonOlaf Valverde MordtPublished in: PLoS neglected tropical diseases (2021)
The trial is registered at ClinicalTrials.gov, number NCT00906880.